+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Vaccine Adjuvants - Market Analysis, Trends, and Forecasts

  • ID: 4806376
  • Report
  • October 2019
  • Region: Global
  • 277 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Agenus, Inc.
  • Avanti Polar Lipids, Inc.
  • Csl
  • Invivogen
  • Mvp Laboratories
  • Novavax
  • MORE
The Vaccine Adjuvants market worldwide is projected to grow by US$492.1 Million, driven by a compounded growth of 10.2%. Particulate Adjuvants, one of the segments analyzed and sized in this study, displays the potential to grow at over 10.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$337.2 Million by the year 2025, Particulate Adjuvants will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$22 Million to the region's size and clout in the next 5 to 6 years. Over US$22.9 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Particulate Adjuvants will reach a market size of US$30.1 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9.7% over the next couple of years and add approximately US$83.7 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Agenus, Inc.
  • Avanti Polar Lipids, Inc.
  • Brenntag Biosector A/S
  • CSL Ltd.
  • Invivogen
  • Mvp Laboratories Inc.
  • Novavax, Inc.
  • OZ Biosciences SAS
  • Seppic SA
  • SPI Pharma
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Agenus, Inc.
  • Avanti Polar Lipids, Inc.
  • Csl
  • Invivogen
  • Mvp Laboratories
  • Novavax
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Vaccine Adjuvants Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Vaccine Adjuvants Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 2: Vaccine Adjuvants Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017

TABLE 3: Vaccine Adjuvants Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Research (Application) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025

TABLE 5: Research (Application) Historic Demand Patterns in US$ Thousand by Region/Country: 2009-2017

TABLE 6: Research (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025

TABLE 7: Commercial (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 8: Commercial (Application) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2009-2017

TABLE 9: Commercial (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 10: Particulate Adjuvants (Type) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 11: Particulate Adjuvants (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017

TABLE 12: Particulate Adjuvants (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Adjuvant Emulsions (Type) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025

TABLE 14: Adjuvant Emulsions (Type) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017

TABLE 15: Adjuvant Emulsions (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 16: Pathogen Components (Type) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025

TABLE 17: Pathogen Components (Type) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017

TABLE 18: Pathogen Components (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Combination Adjuvants (Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025

TABLE 20: Combination Adjuvants (Type) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017

TABLE 21: Combination Adjuvants (Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 22: Other Types (Type) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 23: Other Types (Type) Historic Market Analysis by Region/Country in US$ Thousand:2009 to 2017

TABLE 24: Other Types (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: Infectious Diseases (Disease Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025

TABLE 26: Infectious Diseases (Disease Type) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017

TABLE 27: Infectious Diseases (Disease Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 28: Cancer (Disease Type) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 29: Cancer (Disease Type) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017

TABLE 30: Cancer (Disease Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 31: Other Disease Types (Disease Type) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025

TABLE 32: Other Disease Types (Disease Type) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2009 to 2017

TABLE 33: Other Disease Types (Disease Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

TABLE 34: Subcutaneous (Route of Administration) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025

TABLE 35: Subcutaneous (Route of Administration) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2009 to 2017

TABLE 36: Subcutaneous (Route of Administration) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

TABLE 37: Intramuscular (Route of Administration) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025

TABLE 38: Intramuscular (Route of Administration) Global Historic Demand in US$ Thousand by Region/Country: 2009 to 2017

TABLE 39: Intramuscular (Route of Administration) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 40: Intranasal Route (Route of Administration) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 41: Intranasal Route (Route of Administration) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017

TABLE 42: Intranasal Route (Route of Administration) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 43: Oral Route (Route of Administration) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025

TABLE 44: Oral Route (Route of Administration) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017

TABLE 45: Oral Route (Route of Administration) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 46: Other Route of Administrations (Route of Administration) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025

TABLE 47: Other Route of Administrations (Route of Administration) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017

TABLE 48: Other Route of Administrations (Route of Administration) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 49: Human Vaccine Adjuvants (Application Category) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025

TABLE 50: Human Vaccine Adjuvants (Application Category) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017

TABLE 51: Human Vaccine Adjuvants (Application Category) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 52: Veterinary Vaccine Adjuvants (Application Category) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025

TABLE 53: Veterinary Vaccine Adjuvants (Application Category) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017

TABLE 54: Veterinary Vaccine Adjuvants (Application Category) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Vaccine Adjuvants Market Share (in %) by Company: 2019 & 2025

TABLE 55: United States Vaccine Adjuvants Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025

TABLE 56: Vaccine Adjuvants Historic Demand Patterns in the United States by Application in US$ Thousand for 2009-2017

TABLE 57: Vaccine Adjuvants Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025

TABLE 58: United States Vaccine Adjuvants Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025

TABLE 59: Vaccine Adjuvants Market in the United States by Type: A Historic Review in US$ Thousand for 2009-2017

TABLE 60: United States Vaccine Adjuvants Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 61: United States Vaccine Adjuvants Market Estimates and Projections in US$ Thousand by Disease Type: 2018 to 2025

TABLE 62: Vaccine Adjuvants Market in the United States by Disease Type: A Historic Review in US$ Thousand for 2009-2017

TABLE 63: United States Vaccine Adjuvants Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

TABLE 64: United States Vaccine Adjuvants Market Estimates and Projections in US$ Thousand by Route of Administration: 2018 to 2025

TABLE 65: Vaccine Adjuvants Market in the United States by Route of Administration: A Historic Review in US$ Thousand for 2009-2017

TABLE 66: United States Vaccine Adjuvants Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025

TABLE 67: United States Vaccine Adjuvants Market Estimates and Projections in US$ Thousand by Application Category: 2018 to 2025

TABLE 68: Vaccine Adjuvants Market in the United States by Application Category: A Historic Review in US$ Thousand for 2009-2017

TABLE 69: United States Vaccine Adjuvants Market Share Breakdown by Application Category: 2009 VS 2019 VS 2025

CANADA

TABLE 70: Canadian Vaccine Adjuvants Market Quantitative Demand Analysis in US$ Thousandby Application: 2018 to 2025

TABLE 71: Vaccine Adjuvants Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017

TABLE 72: Canadian Vaccine Adjuvants Market Share Analysis by Application:2009 VS 2019 VS 2025

TABLE 73: Canadian Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025

TABLE 74: Canadian Vaccine Adjuvants Historic Market Review by Type in US$ Thousand:2009-2017

TABLE 75: Vaccine Adjuvants Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 76: Canadian Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018 to 2025

TABLE 77: Canadian Vaccine Adjuvants Historic Market Review by Disease Type in US$ Thousand: 2009-2017

TABLE 78: Vaccine Adjuvants Market in Canada: Percentage Share Breakdown of Sales by Disease Type for 2009, 2019, and 2025

TABLE 79: Canadian Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Route of Administration: 2018 to 2025

TABLE 80: Canadian Vaccine Adjuvants Historic Market Review by Route of Administration in US$ Thousand: 2009-2017

TABLE 81: Vaccine Adjuvants Market in Canada: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025

TABLE 82: Canadian Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Application Category: 2018 to 2025

TABLE 83: Canadian Vaccine Adjuvants Historic Market Review by Application Categoryin US$ Thousand: 2009-2017

TABLE 84: Vaccine Adjuvants Market in Canada: Percentage Share Breakdown of Sales by Application Category for 2009, 2019, and 2025

JAPAN

TABLE 85: Japanese Demand Estimates and Forecasts for Vaccine Adjuvants in US$ Thousand by Application: 2018 to 2025

TABLE 86: Japanese Vaccine Adjuvants Market in US$ Thousand by Application: 2009-2017

TABLE 87: Vaccine Adjuvants Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025

TABLE 88: Japanese Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025

TABLE 89: Vaccine Adjuvants Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017

TABLE 90: Japanese Vaccine Adjuvants Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 91: Japanese Market for Vaccine Adjuvants: Annual Sales Estimates and Projectionsin US$ Thousand by Disease Type for the Period 2018-2025

TABLE 92: Vaccine Adjuvants Market in Japan: Historic Sales Analysis in US$ Thousand by Disease Type for the Period 2009-2017

TABLE 93: Japanese Vaccine Adjuvants Market Share Analysis by Disease Type:2009 VS 2019 VS 2025

TABLE 94: Japanese Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Thousand by Route of Administration for the Period 2018-2025

TABLE 95: Vaccine Adjuvants Market in Japan: Historic Sales Analysis in US$ Thousand by Route of Administration for the Period 2009-2017

TABLE 96: Japanese Vaccine Adjuvants Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025

TABLE 97: Japanese Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Thousand by Application Category for the Period 2018-2025

TABLE 98: Vaccine Adjuvants Market in Japan: Historic Sales Analysis in US$ Thousand by Application Category for the Period 2009-2017

TABLE 99: Japanese Vaccine Adjuvants Market Share Analysis by Application Category: 2009 VS 2019 VS 2025

CHINA

TABLE 100: Chinese Demand for Vaccine Adjuvants in US$ Thousand by Application: 2018 to 2025

TABLE 101: Vaccine Adjuvants Market Review in China in US$ Thousand by Application: 2009-2017

TABLE 102: Chinese Vaccine Adjuvants Market Share Breakdown by Application:2009 VS 2019 VS 2025

TABLE 103: Chinese Vaccine Adjuvants Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025

TABLE 104: Vaccine Adjuvants Historic Market Analysis in China in US$ Thousand by Type: 2009-2017

TABLE 105: Chinese Vaccine Adjuvants Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 106: Chinese Vaccine Adjuvants Market Growth Prospects in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 107: Vaccine Adjuvants Historic Market Analysis in China in US$ Thousand by Disease Type: 2009-2017

TABLE 108: Chinese Vaccine Adjuvants Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 109: Chinese Vaccine Adjuvants Market Growth Prospects in US$ Thousand by Route of Administration for the Period 2018-2025

TABLE 110: Vaccine Adjuvants Historic Market Analysis in China in US$ Thousand by Route of Administration: 2009-2017

TABLE 111: Chinese Vaccine Adjuvants Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 112: Chinese Vaccine Adjuvants Market Growth Prospects in US$ Thousand by Application Category for the Period 2018-2025

TABLE 113: Vaccine Adjuvants Historic Market Analysis in China in US$ Thousand by Application Category: 2009-2017

TABLE 114: Chinese Vaccine Adjuvants Market by Application Category: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Vaccine Adjuvants Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 115: European Vaccine Adjuvants Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025

TABLE 116: Vaccine Adjuvants Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017

TABLE 117: European Vaccine Adjuvants Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 118: European Vaccine Adjuvants Addressable Market Opportunity in US$ Thousand by Application: 2018-2025

TABLE 119: Vaccine Adjuvants Market in Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017

TABLE 120: European Vaccine Adjuvants Market Share Analysis by Application:2009 VS 2019 VS 2025

TABLE 121: European Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025

TABLE 122: Vaccine Adjuvants Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017

TABLE 123: European Vaccine Adjuvants Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 124: European Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018-2025

TABLE 125: Vaccine Adjuvants Market in Europe in US$ Thousand by Disease Type: A Historic Review for the Period 2009-2017

TABLE 126: European Vaccine Adjuvants Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

TABLE 127: European Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Route of Administration: 2018-2025

TABLE 128: Vaccine Adjuvants Market in Europe in US$ Thousand by Route of Administration:A Historic Review for the Period 2009-2017

TABLE 129: European Vaccine Adjuvants Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025

TABLE 130: European Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousandby Application Category: 2018-2025

TABLE 131: Vaccine Adjuvants Market in Europe in US$ Thousand by Application Category:A Historic Review for the Period 2009-2017

TABLE 132: European Vaccine Adjuvants Market Share Breakdown by Application Category:2009 VS 2019 VS 2025

FRANCE

TABLE 133: Vaccine Adjuvants Quantitative Demand Analysis in France in US$ Thousand by Application: 2018-2025

TABLE 134: French Vaccine Adjuvants Historic Market Review in US$ Thousand by Application: 2009-2017

TABLE 135: French Vaccine Adjuvants Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025

TABLE 136: Vaccine Adjuvants Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 137: French Vaccine Adjuvants Historic Market Scenario in US$ Thousand by Type:2009-2017

TABLE 138: French Vaccine Adjuvants Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 139: Vaccine Adjuvants Market in France by Disease Type: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 140: French Vaccine Adjuvants Historic Market Scenario in US$ Thousand by DiseaseType: 2009-2017

TABLE 141: French Vaccine Adjuvants Market Share Analysis by Disease Type:2009 VS 2019 VS 2025

TABLE 142: Vaccine Adjuvants Market in France by Route of Administration: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 143: French Vaccine Adjuvants Historic Market Scenario in US$ Thousand by Route of Administration: 2009-2017

TABLE 144: French Vaccine Adjuvants Market Share Analysis by Route of Administration:2009 VS 2019 VS 2025

TABLE 145: Vaccine Adjuvants Market in France by Application Category: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 146: French Vaccine Adjuvants Historic Market Scenario in US$ Thousand by Application Category: 2009-2017

TABLE 147: French Vaccine Adjuvants Market Share Analysis by Application Category:2009 VS 2019 VS 2025

GERMANY

TABLE 148: Vaccine Adjuvants Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025

TABLE 149: German Vaccine Adjuvants Market in Retrospect in US$ Thousand by Application: 2009-2017

TABLE 150: Vaccine Adjuvants Market Share Distribution in Germany by Application:2009 VS 2019 VS 2025

TABLE 151: Vaccine Adjuvants Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025

TABLE 152: German Vaccine Adjuvants Historic Market Analysis in US$ Thousand by Type:2009-2017

TABLE 153: German Vaccine Adjuvants Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 154: Vaccine Adjuvants Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 155: German Vaccine Adjuvants Historic Market Analysis in US$ Thousand by Disease Type: 2009-2017

TABLE 156: German Vaccine Adjuvants Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

TABLE 157: Vaccine Adjuvants Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Route of Administration for the Period 2018-2025

TABLE 158: German Vaccine Adjuvants Historic Market Analysis in US$ Thousand by Route of Administration: 2009-2017

TABLE 159: German Vaccine Adjuvants Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025

TABLE 160: Vaccine Adjuvants Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Application Category for the Period 2018-2025

TABLE 161: German Vaccine Adjuvants Historic Market Analysis in US$ Thousand by Application Category: 2009-2017

TABLE 162: German Vaccine Adjuvants Market Share Breakdown by Application Category: 2009 VS 2019 VS 2025

ITALY

TABLE 163: Italian Demand for Vaccine Adjuvants in US$ Thousand by Application: 2018 to 2025

TABLE 164: Vaccine Adjuvants Market Review in Italy in US$ Thousand by Application: 2009-2017

TABLE 165: Italian Vaccine Adjuvants Market Share Breakdown by Application:2009 VS 2019 VS 2025

TABLE 166: Italian Vaccine Adjuvants Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025

TABLE 167: Vaccine Adjuvants Historic Market Analysis in Italy in US$ Thousand by Type:2009-2017

TABLE 168: Italian Vaccine Adjuvants Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 169: Italian Vaccine Adjuvants Market Growth Prospects in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 170: Vaccine Adjuvants Historic Market Analysis in Italy in US$ Thousand by Disease Type: 2009-2017

TABLE 171: Italian Vaccine Adjuvants Market by Disease Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 172: Italian Vaccine Adjuvants Market Growth Prospects in US$ Thousand by Route of Administration for the Period 2018-2025

TABLE 173: Vaccine Adjuvants Historic Market Analysis in Italy in US$ Thousand by Route of Administration: 2009-2017

TABLE 174: Italian Vaccine Adjuvants Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 175: Italian Vaccine Adjuvants Market Growth Prospects in US$ Thousand by Application Category for the Period 2018-2025

TABLE 176: Vaccine Adjuvants Historic Market Analysis in Italy in US$ Thousand by Application Category: 2009-2017

TABLE 177: Italian Vaccine Adjuvants Market by Application Category: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 178: United Kingdom Demand Estimates and Forecasts for Vaccine Adjuvants in US$ Thousand by Application: 2018 to 2025

TABLE 179: United Kingdom Vaccine Adjuvants Market in US$ Thousand by Application:2009-2017

TABLE 180: Vaccine Adjuvants Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025

TABLE 181: United Kingdom Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025

TABLE 182: Vaccine Adjuvants Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017

TABLE 183: United Kingdom Vaccine Adjuvants Market Share Analysis by Type:2009 VS 2019 VS 2025

TABLE 184: United Kingdom Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Thousand by Disease Type for the Period 2018-2025

TABLE 185: Vaccine Adjuvants Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Disease Type for the Period 2009-2017

TABLE 186: United Kingdom Vaccine Adjuvants Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025

TABLE 187: United Kingdom Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Thousand by Route of Administration for the Period 2018-2025

TABLE 188: Vaccine Adjuvants Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Route of Administration for the Period 2009-2017

TABLE 189: United Kingdom Vaccine Adjuvants Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025

TABLE 190: United Kingdom Market for Vaccine Adjuvants: Annual Sales Estimates and Projections in US$ Thousand by Application Category for the Period 2018-2025

TABLE 191: Vaccine Adjuvants Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Application Category for the Period 2009-2017

TABLE 192: United Kingdom Vaccine Adjuvants Market Share Analysis by Application Category: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 193: Rest of Europe Vaccine Adjuvants Addressable Market Opportunity in US$ Thousand by Application: 2018-2025

TABLE 194: Vaccine Adjuvants Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017

TABLE 195: Rest of Europe Vaccine Adjuvants Market Share Analysis by Application: 2009 VS 2019 VS 2025

TABLE 196: Rest of Europe Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025

TABLE 197: Vaccine Adjuvants Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017

TABLE 198: Rest of Europe Vaccine Adjuvants Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 199: Rest of Europe Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018-2025

TABLE 200: Vaccine Adjuvants Market in Rest of Europe in US$ Thousand by Disease Type: A Historic Review for the Period 2009-2017

TABLE 201: Rest of Europe Vaccine Adjuvants Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025

TABLE 202: Rest of Europe Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Route of Administration: 2018-2025

TABLE 203: Vaccine Adjuvants Market in Rest of Europe in US$ Thousand by Route of Administration: A Historic Review for the Period 2009-2017

TABLE 204: Rest of Europe Vaccine Adjuvants Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025

TABLE 205: Rest of Europe Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Application Category: 2018-2025

TABLE 206: Vaccine Adjuvants Market in Rest of Europe in US$ Thousand by Application Category: A Historic Review for the Period 2009-2017

TABLE 207: Rest of Europe Vaccine Adjuvants Market Share Breakdown by Application Category: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 208: Vaccine Adjuvants Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2018-2025

TABLE 209: Asia-Pacific Vaccine Adjuvants Historic Market Review in US$ Thousand by Application: 2009-2017

TABLE 210: Asia-Pacific Vaccine Adjuvants Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025

TABLE 211: Vaccine Adjuvants Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 212: Asia-Pacific Vaccine Adjuvants Historic Market Scenario in US$ Thousand by Type: 2009-2017

TABLE 213: Asia-Pacific Vaccine Adjuvants Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 214: Vaccine Adjuvants Market in Asia-Pacific by Disease Type: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 215: Asia-Pacific Vaccine Adjuvants Historic Market Scenario in US$ Thousand by Disease Type: 2009-2017

TABLE 216: Asia-Pacific Vaccine Adjuvants Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025

TABLE 217: Vaccine Adjuvants Market in Asia-Pacific by Route of Administration: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 218: Asia-Pacific Vaccine Adjuvants Historic Market Scenario in US$ Thousand by Route of Administration: 2009-2017

TABLE 219: Asia-Pacific Vaccine Adjuvants Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025

TABLE 220: Vaccine Adjuvants Market in Asia-Pacific by Application Category: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 221: Asia-Pacific Vaccine Adjuvants Historic Market Scenario in US$ Thousand by Application Category: 2009-2017

TABLE 222: Asia-Pacific Vaccine Adjuvants Market Share Analysis by Application Category: 2009 VS 2019 VS 2025

REST OF WORLD

TABLE 223: Rest of World Vaccine Adjuvants Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025

TABLE 224: Vaccine Adjuvants Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017

TABLE 225: Rest of World Vaccine Adjuvants Market Share Analysis by Application: 2009 VS 2019 VS 2025

TABLE 226: Rest of World Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025

TABLE 227: Rest of World Vaccine Adjuvants Historic Market Review by Type in US$ Thousand: 2009-2017

TABLE 228: Vaccine Adjuvants Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 229: Rest of World Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousand by Disease Type: 2018 to 2025

TABLE 230: Rest of World Vaccine Adjuvants Historic Market Review by Disease Type in US$ Thousand: 2009-2017

TABLE 231: Vaccine Adjuvants Market in Rest of World: Percentage Share Breakdown of Salesby Disease Type for 2009, 2019, and 2025

TABLE 232: Rest of World Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousandby Route of Administration: 2018 to 2025

TABLE 233: Rest of World Vaccine Adjuvants Historic Market Review by Route of Administrationin US$ Thousand: 2009-2017

TABLE 234: Vaccine Adjuvants Market in Rest of World: Percentage Share Breakdown of Salesby Route of Administration for 2009, 2019, and 2025

TABLE 235: Rest of World Vaccine Adjuvants Market Estimates and Forecasts in US$ Thousandby Application Category: 2018 to 2025

TABLE 236: Rest of World Vaccine Adjuvants Historic Market Review by Application Categoryin US$ Thousand: 2009-2017

TABLE 237: Vaccine Adjuvants Market in Rest of World: Percentage Share Breakdown of Sales by Application Category for 2009, 2019, and 2025

IV. COMPETITION

AGENUS, INC.

AVANTI POLAR LIPIDS, INC.

BRENNTAG BIOSECTOR A/S (A SUBSIDIARY OF BRENNTAG AG)

CSL

INVIVOGEN

MVP LABORATORIES

NOVAVAX

OZ BIOSCIENCES SAS

SPI PHARMA

SEPPIC SA

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Agenus, Inc.
  • Avanti Polar Lipids, Inc.
  • Brenntag Biosector A/S (A Subsidiary Of Brenntag Ag)
  • Csl
  • Invivogen
  • Mvp Laboratories
  • Novavax
  • Oz Biosciences Sas
  • Spi Pharma
  • Seppic Sa
Note: Product cover images may vary from those shown
Adroll
adroll